We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · June 27, 2022

DMARD Disruption, Disease Flare, and Prolonged Symptom Duration After Acute COVID-19 Among Patients With Rheumatic Disease

Seminars in Arthritis and Rheumatism


Additional Info

Seminars in Arthritis and Rheumatism
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study
Semin. Arthritis Rheum. 2022 Feb 09;28(2022)152025, M Di Iorio, CE Cook, KMM Vanni, NJ Patel, KM D'Silva, X Fu, J Wang, LC Prisco, E Kowalski, A Zaccardelli, LW Martin, G Qian, TY Hsu, ZS Wallace, JA Sparks

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading